CTLA4 and metastatic melanoma: We analyzed two datasets, “Van Allen et al., Science 2015” and “Snyder et al., NEJM 2014,” derived from two clinical trials of anti-CTLA4 therapy for metastatic melanoma patients (Snyder et al., 2014; Van Allen et al., 2015).